Pediatric Multiple Sclerosis: Gilenya (fingolimod)
First drug approved for children with multiple sclerosis.
Pediatric Partial Onset Seizures: Briviact (brivaracetam)
Indication for partial onset seizures expanded to include children aged 4 years or older.
Medscape © 2018 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Mary L Windle. FDA New Drug and Biologic Approvals, 2018 Midyear Review - Medscape - Aug 01, 2018.